Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Maastricht University Medical Center
Maastricht University Medical Center
DEKA Biosciences
Eli Lilly and Company
OHSU Knight Cancer Institute
Tempest Therapeutics
Fate Therapeutics
Five Prime Therapeutics, Inc.
Western Regional Medical Center